Preparation and Evaluation of Co-amorphous Formulations of Telmisartan-Amino Acids as a Potential Method for Solubility and Dissolution Enhancement.
AAPS PharmSciTech
; 22(3): 112, 2021 Mar 21.
Article
em En
| MEDLINE
| ID: mdl-33748914
ABSTRACT
Telmisartan (TLM) is a potent antihypertensive drug with pH-dependent aqueous solubility. This work aimed to enhance the solubility and dissolution rate of TLM by the co-amorphous drug amino acid (AA) approach by combining TLM, with different types and ratios of AAs. The co-amorphous TLM-AA blends were prepared by freeze-drying and investigated for solid-state characteristics like the dissolution rate enhancement of TLM. Among the prepared co-amorphous formulations, TLM-arginine (ARG) exhibited the greatest enhancement in solubility with increasing the molar ratio of ARG. The TLM-ARG at 12 ratio showed about a 57-fold increase in solubility of TLM and the highest dissolution percentage in phosphate buffer (pH7.5) (100% in 20 minutes) compared to both crystalline TLM (20% in 60 min) and physical mixture. Powder XRD, DSC, FTIR analysis and SEM demonstrated the formation of amorphous form within the co-amorphous formulations. Only TLMARG (10.5) were stable at (40°C, 75% RH) for a minimum of 90 days. In conclusion, ARG was able to stabilize the amorphous form of TLM and enhances its aqueous solubility and dissolution. The 12 w/w ratio of TLM-ARG co-amorphous showed the best solubility and dissolution rate while the 10.5 w/w ratio showed the best stability.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Bloqueadores do Receptor Tipo 1 de Angiotensina II
/
Telmisartan
/
Aminoácidos
Idioma:
En
Ano de publicação:
2021
Tipo de documento:
Article